British Columbia Investment Management Corp Biogen Inc. Transaction History

British Columbia Investment Management Corp

$16.2 Billion
Q2 2024

A detailed history of British Columbia Investment Management Corp transactions in Biogen Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 27,838 shares of BIIB stock, worth $4.84 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

27,838

Previous 17,299 60.92%

Holding current value

$4.84 Million

Previous $3.73 Million 73.0%

% of portfolio

0.04%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $2.01 Million - $2.49 Million	10,539 Added 60.92%	27,838 $6.45 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $133,148 - $168,121	628 Added 3.77%	17,299 $3.73 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $781,958 - $941,273	3,513 Added 26.7%	16,671 $4.31 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $32,675 - $36,879	129 Added 0.99%	13,158 $3.38 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $38,259 - $44,210	139 Added 1.08%	13,029 $3.71 Million
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $403,904 - $490,752	-1,600 Reduced 11.04%	12,890 $3.57 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $500,937 - $690,747	-2,573 Reduced 15.08%	14,490 $3.87 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $1.05 Million - $1.25 Million	-5,618 Reduced 24.77%	17,063 $3.48 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $695,246 - $875,974	-3,588 Reduced 13.66%	22,681 $4.78 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $357,376 - $459,280	-1,596 Reduced 5.73%	26,269 $6.3 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $98,197 - $128,060	-347 Reduced 1.23%	27,865 $7.89 Million
Q2 2021 Aug 09, 2021	BUY	$259.0 - $414.71 $767,158 - $1.23 Million	2,962 Added 11.73%	28,212 $9.77 Million
Q1 2021 Apr 30, 2021	SELL	$242.95 - $284.63 $375,114 - $439,468	-1,544 Reduced 5.76%	25,250 $7.06 Million
Q4 2020 Feb 02, 2021	SELL	$236.26 - $355.63 $356,280 - $536,290	-1,508 Reduced 5.33%	26,794 $6.56 Million
Q3 2020 Nov 10, 2020	BUY	$264.77 - $305.71 $108,290 - $125,035	409 Added 1.47%	28,302 $8.03 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $2.1 Million - $2.78 Million	8,125 Added 41.1%	27,893 $7.46 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $6.39 Million - $8.1 Million	-23,756 Reduced 54.58%	19,768 $6.25 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $161,964 - $223,795	-736 Reduced 1.66%	43,524 $12.9 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $8.34 Million - $9.36 Million	-38,378 Reduced 46.44%	44,260 $10.3 Million
Q2 2019 Aug 12, 2019	BUY	$219.29 - $241.72 $1.99 Million - $2.2 Million	9,094 Added 12.37%	82,638 $19.3 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $4.32 Million - $6.76 Million	-19,943 Reduced 21.33%	73,544 $17.4 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $536,391 - $679,396	1,926 Added 2.1%	93,487 $28.1 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $3.42 Million - $4.47 Million	-11,648 Reduced 11.29%	91,561 $32.3 Million
Q2 2018 Aug 09, 2018	SELL	$257.52 - $306.91 $11.9 Million - $14.2 Million	-46,221 Reduced 30.93%	103,209 $30 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $2.81 Million - $3.97 Million	-10,800 Reduced 6.74%	149,430 $40.9 Million
Q4 2017 Feb 20, 2018	BUY	$307.64 - $344.58 $12 Million - $13.5 Million	39,136 Added 32.32%	160,230 $51 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $34 Million - $39.9 Million	121,094	121,094 $37.9 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Biogen Inc. Transaction History